vitamin b7

Biotin, also known as vitamin B7 or vitamin H, is a water‑soluble member of the B vitamin family that is essential for human metabolism. Unlike many vitamins that have defined Recommended Dietary Allowances (RDAs), biotin is assigned Adequate Intake (AI) levels due to limited evidence on exact requirements; for adults these are set at about 30 micrograms daily and slightly higher for lactating women. Biochemically, biotin consists of an ureido ring fused with a tetrahydrothiophene ring attached to a valeric acid side chain, enabling it to function as a cofactor for carboxylase enzymes integral to fatty acid synthesis, gluconeogenesis, and branched‑chain amino acid catabolism in the human body. The human body cannot synthesize biotin de novo and must obtain it from dietary sources and, to a smaller extent, intestinal microbial synthesis. In foods, biotin is typically protein‑bound, and the intestinal enzyme biotinidase releases free biotin for absorption through the sodium‑dependent multivitamin transporter primarily in the jejunum. Biotin’s roles extend beyond basic metabolism; emerging research suggests roles in gene regulation via histone biotinylation and modulating inflammatory pathways, although these areas remain active fields of investigation. The vitamin’s discovery dates back to early 20th century experiments that identified a factor in egg yolk preventing dermatitis in animals, leading to its classification as a B vitamin. In normal nutrition, biotin status is maintained by a balance of dietary intake, recycling via biotinidase, and excretion, with excess rapidly eliminated in urine due to its water solubility. Its widespread presence in many common foods and endogenous biosynthesis by gut bacteria mean deficiency from diet alone is rare in healthy populations.

Biotin’s primary biochemical function in the body is to serve as an enzymatic cofactor for five carboxylase enzymes that catalyze critical metabolic reactions. These include pyruvate carboxylase, which aids in gluconeogenesis, and acetyl‑CoA carboxylases that help regulate fatty acid synthesis, as well as methylcrotonyl‑CoA carboxylase and propionyl‑CoA carboxylase involved in branched‑chain amino acid and odd‑chain fatty acid metabolism. Through these pathways, biotin supports efficient energy production and the processing of macronutrients. Beyond metabolism, biotin has been studied for a variety of health roles. Some research suggests biotin may influence gene expression and chromatin structure via histone biotinylation, although clinical implications remain to be fully clarified in high‑quality human trials. Preliminary mechanistic research indicates biotin status may modulate inflammatory cytokine production and influence glucose and lipid metabolism via gene regulatory pathways, suggesting potential therapeutic roles in conditions like diabetes and inflammatory disorders, though robust clinical evidence is limited. While biotin supplements are widely marketed for hair, skin, and nail health, the scientific data supporting these uses in people without deficiency are inconsistent; NIH states that little evidence supports biotin supplementation for these beauty outcomes in the general population, despite small studies showing benefits in select individuals with thin nails or rare hair disorders. However, when deficiency is present, hair loss, brittle nails, and skin rash are well‑documented manifestations. Because biotin plays a role in central metabolic pathways, maintaining adequate intake through diet contributes to metabolic homeostasis and energy turnover, particularly important in growth, pregnancy, and lactation. Some research also explores biotin status in neurological conditions and its interaction with gut microbiota, but these areas require further clinical trials for conclusive recommendations. Overall, biotin supports essential biochemical processes that underpin energy production and macronutrient metabolism, with additional potential benefits under investigation.

Biotin requirements are expressed as Adequate Intake (AI) levels due to insufficient data to establish a more precise Recommended Dietary Allowance. For infants aged 0–6 months, the AI is 5 mcg per day, increasing slightly to 6 mcg for 7–12 months. Early childhood needs are modest, with AIs of 8 mcg for ages 1–3 years, 12 mcg for ages 4–8 years, and 20 mcg for ages 9–13 years. Adolescents aged 14–18 have an AI of 25 mcg daily. Adults aged 19 years and older typically require an AI of 30 mcg per day; pregnant women also aim for 30 mcg daily while lactating women have a slightly higher AI of 35 mcg per day to account for transfer through breast milk. These intake levels are based on observational intake data and estimated average intakes in healthy populations. Factors that can affect biotin needs include genetic disorders such as biotinidase deficiency and holocarboxylase synthetase deficiency, which impair biotin recycling and utilization, respectively, requiring pharmacological biotin doses for management. Other conditions such as prolonged use of anticonvulsant medications, long‑term antibiotic use that alters gut microbiota, and situations that increase metabolic demands (e.g., pregnancy, rapid growth) may warrant monitored intake and, in some cases, supplementation. It is important to note that food processing and cooking can alter biotin availability in foods. For example, raw egg whites contain avidin, a protein that strongly binds biotin and inhibits its absorption; cooking denatures avidin, reducing this effect. Optimal versus minimum intake can vary with individual metabolic health and life stages, but for most healthy individuals, a varied diet providing the AI levels is sufficient to maintain adequate biotin status.

True biotin deficiency due to inadequate dietary intake is rare in typical Western diets because biotin is widely distributed in foods and the gut microbiota contributes to biotin availability. However, deficiency can occur due to genetic conditions such as biotinidase deficiency and holocarboxylase synthetase deficiency, where biotin cannot be effectively recycled or attached to enzymes, leading to systemic lack. Early clinical signs of biotin deficiency include thinning hair, brittle nails, and a red scaly rash, particularly around facial orifices. Neurological symptoms such as lethargy, ataxia, seizures, and developmental delays are associated with severe deficiency or genetic disorders. Laboratory features may include elevated organic acids due to impaired carboxylase activity. Infants with biotinidase deficiency may present with hypotonia, feeding difficulties, breathing problems, and immune dysfunction early in life; if untreated, outcomes can be severe. Secondary deficiency may also arise from prolonged use of certain medications like anticonvulsants, which can increase biotin metabolism, or prolonged total parenteral nutrition lacking adequate biotin. Signs in adults may be subtle initially but can include fatigue, depression, and paresthesia. There is no widely used routine blood test for biotin status in healthy populations; diagnosis is often clinical and supported by specialized metabolic assays. At‑risk populations include individuals with genetic disorders, those undergoing prolonged anticonvulsant therapy, and people with chronic alcohol use or significant malabsorption conditions. Early recognition and treatment are crucial, particularly in infants with genetic deficiencies, where prompt biotin administration can prevent irreversible neurological damage.

Biotin is found in a variety of foods across animal and plant food groups, making it accessible through diverse dietary patterns. Organ meats such as chicken and beef liver are among the richest sources; for example, a 3‑ounce serving of chicken liver provides a very high amount of biotin, often exceeding daily needs. Eggs, particularly cooked whole eggs, are excellent sources, though raw egg whites contain avidin, a protein that binds biotin and inhibits absorption until denatured by heat. Fish such as salmon, legumes including soybeans and peanuts, nuts and seeds such as sunflower seeds and almonds, and certain vegetables including sweet potatoes and mushrooms all contribute meaningful amounts of biotin. Whole grains and cereals can also provide biotin, though content varies with grain type and processing. Biotin content in foods can be expressed in micrograms per serving; for instance, 3 ounces of chicken liver may provide well over 100 mcg, while typical nuts and seeds contribute smaller but useful amounts. Dietary diversity helps ensure adequate intake; combining sources from both animal and plant foods accommodates different dietary preferences. Additionally, fermented foods such as tempeh derived from soybeans provide biotin in appreciable amounts. Because biotin is water‑soluble and evenly distributed through many proteins and macronutrient groups, individuals consuming balanced diets with adequate protein and plant foods generally meet the recommended intake. Awareness of specific food biotin content and absorption factors, such as the negative effect of raw egg avidin, supports practical dietary planning.

Biotin from food exists bound to proteins and requires release by the intestinal enzyme biotinidase to be absorbed in the small intestine. Once freed, biotin is absorbed primarily in the jejunum via the sodium‑dependent multivitamin transporter. Because biotin is water‑soluble, its absorption is not saturable at typical dietary doses, and excess biotin is rapidly excreted in urine. The gut microbiota synthesizes biotin, some of which is absorbed and contributes to overall status. Bioavailability can be inhibited by the protein avidin in raw egg whites, which binds biotin strongly; cooking denatures avidin and prevents this interaction. High dietary fiber and certain medications affecting gut integrity may influence biotin absorption, while fat content in meals does not significantly affect uptake. Overall, bioavailability from typical dietary sources is adequate to meet needs in most healthy individuals.

Supplementation with biotin may be indicated in specific clinical scenarios such as genetic deficiencies, long‑term anticonvulsant therapy, or research protocols under physician guidance. For most healthy individuals consuming balanced diets, supplementation beyond dietary intake is not necessary and does not confer proven benefits for hair, skin, or nails in the absence of deficiency. Biotin supplements are available in various forms including tablets, capsules, and gummies, often at doses ranging from 30 mcg to several milligrams — far exceeding typical AI levels. Quality considerations include third‑party testing for purity and accurate labeling since dietary supplements are not regulated as strictly as medications. Consultation with healthcare professionals is advised before beginning supplementation, particularly if undergoing laboratory testing, as high blood levels of biotin can interfere with assays measuring hormones and cardiac biomarkers, potentially leading to misdiagnosis or inappropriate clinical decisions.

Biotin has no established Tolerable Upper Intake Level (UL) because toxicity is rare and excess biotin is excreted in the urine. Reports indicate that even very high supplemental doses, up to hundreds of milligrams daily, are generally well tolerated; however, supraphysiological levels can interfere with laboratory tests that use biotin‑streptavidin technology, making clinical interpretation unreliable. Symptoms specifically attributable to biotin toxicity are not well defined due to the lack of adverse effect reports at high doses. Nonetheless, individuals taking large supplemental doses should inform healthcare providers before blood tests and discuss appropriate timing of cessation prior to testing to avoid misleading results.

Biotin itself is not known to directly interact with most medications to alter their effectiveness, but certain drugs can influence biotin status. Anticonvulsant medications such as carbamazepine, phenytoin, and phenobarbital may increase biotin metabolism and lead to lower levels, potentially necessitating supplementation under medical supervision. Long‑term antibiotic use can reduce gut microbiota that contribute to endogenous biotin production, which theoretically could affect overall status. Importantly, high levels of supplemental biotin can interfere with laboratory assays that use biotin‑streptavidin binding, including tests for thyroid‑stimulating hormone (TSH), cardiac troponin, and hormone panels, leading to falsely low or high readings. Communicating biotin supplement use to clinicians and laboratories is crucial to avoid misinterpretation of test results. Overall, while direct pharmacokinetic interactions are limited, the impact on diagnostic tests is a significant clinical consideration.

Common Forms: tablets, capsules, gummies

Typical Doses: 30 mcg daily for general needs; therapeutic doses higher under physician guidance

When to Take: with meals for routine use

Best Form: standard D‑biotin in microgram to milligram doses

⚠️ Interactions: anticonvulsants may lower biotin levels, biotin may interfere with lab tests